Apexigen vs Y-mAbs Therapeutics, Inc.
Apexigen
Creating Transformative Immunotherapies for Patients with Cancer
11 employees · est. 2010 · San Carlos, United States
Y-mAbs Therapeutics, Inc.
Innovative pediatric immunotherapies for Real-life Possibilities
59 employees · est. 2015 · New York, United States
Apexigen is the older company (2010 vs 2015); Y-mAbs Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Apexigen | Y-mAbs Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2010 older | 2015 |
| Headquarters | ||
| Headquarters | San Carlos, United States | New York, United States |
| Employees | ||
| Employees | 11 | 59 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $175.80M | $338.80M |
| Funding Rounds | ||
| Funding Rounds | 6 | 4 |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical CompanyClinical-stageAntibody TherapeuticsImmunotherapyCancer TreatmentImmuno-oncology +6 | Pediatric ImmunotherapiesOncology ProductsAntibody-based TherapeuticsClinical Biopharmaceutical CompanyCancer TreatmentMedical Needs +9 |
| Website | ||
| Website | apexigen.com | ymabs.com |
About Apexigen
Apexigen is a clinical-stage biopharmaceutical company founded in 2010 with a focus on creating transformative immunotherapies for patients with cancer. The company is dedicated to discovering and developing a new generation of antibody therapeutics for the treatment of cancer, particularly emphasiz...
About Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. is a commercial-stage clinical biopharmaceutical company founded in 2015, headquartered in the United States. The company is dedicated to developing and commercializing innovative pediatric immunotherapies for the treatment of cancer. With a broad and advanced product pipel...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Apexigen and Y-mAbs Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Apexigen or Y-mAbs Therapeutics, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Apexigen with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Apexigen on 12 Sep 2024, and Y-mAbs Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
